DESIREE DEMANAWA: Open Payments
NPI 1740973577 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 12 payments from 9 companies in 2025. Trend: 2023 $33 · 2024 $31 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $213 |
| UROGEN PHARMA, INC. | 2 | $39 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $36 |
| TOLMAR, INC. | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $26 |
| Olympus America Inc. | 1 | $22 |
| IMMUNITYBIO, INC. | 1 | $20 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: INTERSTIM, Aptra, JATENZO, MYRISK, iTIND System, ANKTIVA, JELMYTO, PYLARIFY.
Industry payments across TX — which companies pay providers there.
